Recombinant Human VSIG4 Protein (HEK293)，Avi & His

H-2Db and β2-microglobulin (β2M) are critical components of the major histocompatibility complex (MHC) class I molecules in mice, playing essential roles in the immune response by presenting peptide antigens to CD8+ T cells. The reconstitution of H-2Db with β2M in recombinant protein studies is crucial for understanding various aspects of immune system functioning, including T cell activation, antigen recognition, and the overall dynamics of adaptive immunity. The incorporation of β2M is necessary for the proper folding, stability, and expression of the H-2Db alpha chain, which is pivotal for functional MHC class I molecules. Research involving the recombinant expression of H-2Db and β2M facilitates detailed analyses of their interactions, the mechanisms of antigen presentation, and the implications for diseases, such as viral infections and cancer, where MHC class I molecules play a significant role. Moreover, recombinant proteins can be valuable tools for developing vaccines, studying T cell receptor binding, and designing immunotherapies. Understanding the structural and functional properties of the H-2Db/β2M complex allows researchers to explore novel therapeutic strategies to modulate immune responses. Through the investigation of these proteins, scientists can gain insights into the fundamental mechanisms of immune recognition and tolerance, contributing to advancements in immunology and biotechnology.